Eli Lilly

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Eli Lilly 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About LLY

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. 

CEO
David A. Ricks
CEODavid A. Ricks
Employees
47,000
Employees47,000
Headquarters
Indianapolis, Indiana
HeadquartersIndianapolis, Indiana
Founded
1876
Founded1876
Employees
47,000
Employees47,000

LLY Key Statistics

Market cap
963.36B
Market cap963.36B
Price-Earnings ratio
50.71
Price-Earnings ratio50.71
Dividend yield
0.57%
Dividend yield0.57%
Average volume
5.24M
Average volume5.24M
High today
$1,027.25
High today$1,027.25
Low today
$998.30
Low today$998.30
Open price
$1,003.76
Open price$1,003.76
Volume
1.66M
Volume1.66M
52 Week high
$1,033.62
52 Week high$1,033.62
52 Week low
$623.78
52 Week low$623.78

Stock Snapshot

With a market cap of 963.36B, Eli Lilly(LLY) trades at $1,019.01. The stock has a price-to-earnings ratio of 50.71 and currently yields dividends of 56.6%.

During the trading session on 2025-11-17, Eli Lilly(LLY) shares reached a daily high of $1,027.25 and a low of $998.30. At a current price of $1,019.01, the stock is +2.1% higher than the low and still -0.8% under the high.

Trading volume for Eli Lilly(LLY) stock has reached 1.66M, versus its average volume of 5.24M.

Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,033.62 and a low of $623.78.

Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,033.62 and a low of $623.78.

LLY News

TipRanks 32m
Eli Lilly Stock Falls as Rival Novo Nordisk Cuts Weight-Loss Drug Prices

The stock of pharmaceutical company Eli Lilly (LLY) is down 1% on Nov. 17 after news broke that rival Novo Nordisk (NVO) has lowered the direct-to-consumer pric...

Investor's Business Daily 1h
How Novo Nordisk Just Undercut Eli Lilly And The Trump Administration

Novo Nordisk (NVO) undercut Eli Lilly (LLY) and the Trump administration on Monday, slashing the cash price of its drugs Wegovy and Ozempic to just $349 a month...

How Novo Nordisk Just Undercut Eli Lilly And The Trump Administration
Barron's 2h
Eli Lilly Could Be Next Company to Split Its Stock

North America Barron's Take Eli Lilly Could Be Next Company to Split Its Stock Stock splits bring in new investors in. Netflix, just days away from splitting, i...

Eli Lilly Could Be Next Company to Split Its Stock

Analyst ratings

74%

of 31 ratings
Buy
74.2%
Hold
22.6%
Sell
3.2%

More LLY News

Seeking Alpha 2h
Novo Nordisk cuts Wegovy, Ozempic direct-to-user prices to match Eli Lilly’s Zepbound

Novo Nordisk (NVO) is cutting prices to challenge rival Eli Lilly (LLY) in the obesity-drug market, signaling a more aggressive push to regain U.S. market share...

Novo Nordisk cuts Wegovy, Ozempic direct-to-user prices to match Eli Lilly’s Zepbound
TipRanks 3h
Novo Nordisk undercuts Lilly’s obesity drug U.S. cash-pay price, Bloomberg says

Danish drugmaker Novo Nordisk (NVO) announced that introductory doses of blockbuster weight loss drugs Wegovy and Ozempic will be available for U.S. cash-pay pr...

The Motley Fool 23h
Eli Lilly and Novo Nordisk May Soon Sell Weight Loss Drugs on the Planned TrumpRx. Could This Further Boost the Healthcare Giants' Stocks?

Investors will be watching what Trump makes happen. Don't look now, but the costs of America's beloved weight loss drugs are about to come down. Way down. At l...

Eli Lilly and Novo Nordisk May Soon Sell Weight Loss Drugs on the Planned TrumpRx. Could This Further Boost the Healthcare Giants' Stocks?
The Motley Fool 23h
Prediction: This Will Be Wall Street's Next Trillion-Dollar Stock

Drugs for weight loss and diabetes are taking Eli Lilly to new heights. The $1 trillion club in the stock market is exclusive. Only 10 companies currently make...

Prediction: This Will Be Wall Street's Next Trillion-Dollar Stock
Nasdaq 1d
Guru Fundamental Report for LLY

Below is Validea's guru fundamental report for ELI LILLY AND CO (LLY). Of the 22 guru strategies we follow, LLY rates highest using our Quantitative Momentum In...

Guru Fundamental Report for LLY
Benzinga 2d
Eli Lilly Supremacy: How One Stock Is Dictating Performance Across Pharma ETFs

Eli Lilly And Co (NYSE:LLY) has officially become the giant quietly moving the strings behind a large slice of the pharma ETF universe. With blockbuster revenue...

Eli Lilly Supremacy: How One Stock Is Dictating Performance Across Pharma ETFs
TipRanks 2d
Eli Lilly, GM, IonQ, Merck, MARA: Insider Moves Unveiled!

Insiders have been trading these 5 stocks: ((LLY)), ((GM)), ((IONQ)), ((MRK)) and ((MARA)). Here is a breakdown of their recent trades and their value. Meet Yo...

People also own

Based on the portfolios of people who own LLY. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.